Plasma fibronectin is initially decreased during septicemia.

Area of Science:

• Biochemistry
• Immunology
• Critical Care Medicine

Background:

• Plasma fibronectin (PFN) is a key protein in immune response and tissue repair.
• Sepsis can lead to significant alterations in plasma protein levels, impacting patient outcomes.
• Understanding PFN dynamics in sepsis is crucial for effective clinical management.

Purpose of the Study:

• To investigate serial changes in plasma fibronectin (PFN) levels in septic patients.
• To compare PFN levels between different etiologies of sepsis (Gram-positive vs. Gram-negative).
• To assess the prognostic significance of PFN levels in sepsis with favorable outcomes.

Main Methods:

• Radioimmunoassay was used to measure PFN levels.
• 24 normal individuals served as a control group.
• 24 septic patients without major trauma were monitored serially during antibiotic therapy.

Main Results:

• Septic patients exhibited an initial decrease in PFN levels, followed by normalization within two weeks of antibiotic treatment.
• Mean nadir PFN levels were significantly lower in septic patients compared to controls (p < 0.001).
• Gram-positive sepsis cases showed lower mean PFN values than Gram-negative cases (p < 0.05).

Conclusions:

• Transient depletion of plasma fibronectin is a consistent finding in sepsis patients with favorable outcomes.
• A single low PFN level in sepsis does not warrant fibronectin replacement therapy.
• Low PFN levels alone do not indicate a poor prognosis in sepsis.